Foamix Pharmaceuticals (FOMX) Stock Pops After IPO Pricing

NEW YORK (TheStreet) -- Shares of Foamix Pharmaceuticals  (FOMX) surged 23.17% to $7.39 in morning trading Thursday after the company announced the pricing of its IPO.

The pharmaceutical company, which specializes in topical foams for dermatological applications, announced the offering of 6.7 million shares at $6 a share. The offering, which the company expects to close on Tuesday, contains a 30-day option to purchase up to 1,005,000 additional shares.

The stock opened at $8 on Thursday and spiked to a high of $11. More than 10.2 million shares had changed hands as of 10:52 a.m.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

FOMX Price Chart FOMX Price data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%